Assessing Arcellx (ACLX) Valuation After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Arcellx, Inc. (ACLX)
Company Research
Source: Yahoo! Finance
Arcellx (ACLX) is drawing attention after a period of strong share price moves, with the stock recently closing at US$114.80 and delivering very large total returns over the past three years. See our latest analysis for Arcellx. Recent moves have been relatively steady, with a 90 day share price return of 76.6% and an 81.2% year to date share price return, alongside a 114.2% 1 year total shareholder return. This points to strong positive momentum. If Arcellx has caught your eye, it can be helpful to compare it with other biotech names harnessing AI in healthcare, starting with 37 healthcare AI stocks With Arcellx trading around US$114.80, a recent intrinsic value estimate points to a large discount. However, the stock also sits slightly above one analyst price target. Is this a genuine opportunity, or is the market already pricing in future growth? Price to Book of 16.7x: Is it justified? Arcellx is currently trading on a P/B of 16.7x, and that sits well below a peer grou
Show less
Read more
Impact Snapshot
Event Time:
ACLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACLX alerts
High impacting Arcellx, Inc. news events
Weekly update
A roundup of the hottest topics
ACLX
News
- Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom [Yahoo! Finance]Yahoo! Finance
- Gilead to buy Ouro Medicines for up to $2.2 billion [Yahoo! Finance]Yahoo! Finance
- Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research [Yahoo! Finance]Yahoo! Finance
- Arcellx (ACLX) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".MarketBeat
ACLX
Earnings
- 2/26/26 - Miss
ACLX
Sec Filings
- 4/21/26 - Form 4
- 4/21/26 - Form SC
- 4/17/26 - Form 4
- ACLX's page on the SEC website